%PDF-1.7
%
1 0 obj
<>stream
application/pdf20323 - 04GAVAGEResveratrolMICE90-DAYE05: CLINICAL OBSERVATIONS SUMMARYENTDMSE
endstream
endobj
2 0 obj
<>/Type/StructTreeRoot/K[3 0 R]/ParentTree 4 0 R>>
endobj
3 0 obj
<>
endobj
4 0 obj
<>
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
7 0 obj
<>
endobj
8 0 obj
<>
endobj
9 0 obj
<>
endobj
10 0 obj
<>
endobj
13 0 obj
<>>>/MediaBox[0 0 612 792]/StructParents 0/Rotate 90>>
endobj
15 0 obj
<>
endobj
16 0 obj
<>stream
x]o0vQUe
iX]M4l
@*ϴv6hDcc\Lh<8A7LQ7u
V./a6µK>n<
d쁃dGZo||cs
}o{S#YĤc>{S|9A(P&%ew8=m^w><\ԒZM!mi P!uңjj
iK}z,jXlٱ|F;VkH9>
< t&wkj%\>XY*ϧzXhɥ!m;8!mgXb?vF>~V6\
!m-Ne-Pө7H_cs\MI~E~`SЦy
@@@T)Dfk6VWүInY.MY
;U=YݰTD1b>
endobj
18 0 obj
<>
endobj
14 0 obj
<>>>/MediaBox[0 0 612 792]/StructParents 1/Rotate 90>>
endobj
19 0 obj
<>stream
xn@yl,8ZQʀH$ɶrUJ}.N/`G33` `;ՊE